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Summary
Cadherin adhesion molecules function in close cooperation
with the actin cytoskeleton. At the zonula adherens (ZA) of
polarized epithelial cells, E-cadherin adhesion induces the
cortical recruitment of many key cytoskeletal regulators,
which act in a dynamic integrated system to regulate junc-
tional integrity and cell-cell interactions [1–3]. This capacity
for the cytoskeleton to support the ZA carries the implication
that regulators of the junctional cytoskeleton might also be
targeted to perturb junctional integrity. In this report, we
now provide evidence for this hypothesis. We show that
hepatocyte growth factor (HGF), which is well-known to
disrupt cell-cell interactions, acutely perturbs ZA integrity
much more rapidly than generally appreciated. This is
accompanied by significant loss of junctional F-actin,
a process that reflects loss of filament anchorage at the junc-
tions. We demonstrate that this involves uncoupling of the
unconventional motormyosin VI from junctional E-cadherin,
a novel effect of HGF that is mediated by intracellular
calcium. We conclude that regulators of the junctional cyto-
skeleton are likely to be major targets for cadherin junctions
to be acutely modulated in development and perturbed in
disease.
Results and Discussion
Hepatocyte growth factor (HGF) drives epithelial-to-mesen-
chymal transformations during development and promotes
tumor invasiveness [4–8], processes distinguished by remod-
eling or disruption of cell-cell interactions. Similarly, after
several hours of treatment with HGF, subconfluent-cultured
epithelial cells separate from one another and scatter [9, 10].
This late disruptive impact on cell-cell junctions has been
attributed to tyrosine phosphorylation of cadherin and/or cat-
enin [11, 12] and increased cellular contractility [10].
We now report that HGF also very rapidly disrupts junctional
integrity in established Caco-2 epithelial monolayers. Control
cells displayed E-cadherin staining in a continuous apical
ring, marking the zonula adherens (ZA) (Figure 1A), as well as
in subapical clusters [3] (not shown). Within 15 min of HGF
(5 ng/ml), however, the linear integrity of the apical ZA cadherin
ring became fragmented by numerous discontinuities (Figures*Correspondence: a.yap@uq.edu.au1A and 1D). In contrast, tight junction integrity, marked by
ZO-1 (Figure 1B), remained largely unaffected. Thus HGF has
the capacity to perturb epithelial cell-cell interactions at
a much earlier stage than often appreciated, preferentially
affecting the cadherin-based ZA.
HGF-induced disruption in E-cadherin organization was
accompanied by a dramatic change in the junctional actin
cytoskeleton. Control cultures displayed intense junctional
phalloidin staining (Figure 1C) that accumulated in dense
apical actin rings directly adjacent to the ZA itself [3]. After
15 min of HGF treatment, apical actin rings were much less
evident (Figure 1C) and peak actin fluorescence intensity
was reduced (Figures 1E and 1F). Many cells instead displayed
apical ruffles and prominent basal stress fibers, as has been
reported recently [13]. Overall, these findings indicate that
HGF can acutely and apparently coordinately disrupt the
integrity of the ZA and its adjacent actin cytoskeleton.
This acute impact of HGF on junctional F-actin prompted us
to investigate whether regulators of the junctional cytoskel-
eton might be targeted by HGF signaling. One interesting
candidate was myosin VI, which localizes with E-cadherin
at cell-cell contacts, coimmunoprecipitates with the E-cad-
herin/catenin complex [1, 14], and functionally cooperates
with DE-cadherin during border cell migration in Drosophila
[14]. We previously showed that myosin VI RNAi fragments
E-cadherin organization and reduces F-actin at epithelial
junctions, changes very similar to the acute effects of HGF
[1]. Furthermore, we report here for the first time that myosin
VI and E-cadherin can interact directly in vitro (Figure 2A).
Purified recombinant proteins of the cargo-binding domain
(CBD) of myosin VI and of the E-cadherin cytoplasmic tail
bound one another in vitro, as assessed by Coomassie stain-
ing and immunoblotting for the Myc-tagged myosin VI CBD
(Figure 2A). Moreover, binding was effectively reduced by
increasing concentrations of a CBD construct lacking the
Myc tag (data not shown).
We therefore sought to determine whether myosin VI might
be a target for the junctional effects of HGF. Myosin VI local-
ized to the ZA in confluent Caco-2 monolayers (Figure 2B),
as well as in previously reported cytoplasmic puncta, and it
coimmunoprecipitated with E-cadherin (Figures 2E and 2F).
HGF, however, significantly reduced the junctional staining
of myosin VI (Figures 2B and 2C); this was not attributable to
changes in E-cadherin levels at the ZA because the ratio of
myosin VI fluorescence intensity decreased relative to that
of E-cadherin (Figure 2D). Furthermore, although total cellular
levels of E-cadherin and myosin VI were unchanged
(Figure S1A, available online), HGF reduced the amount of
E-cadherin that coimmunoprecipitatedwithmyosin VI (Figures
2E and 2F). Thus the association of myosin VI with E-cadherin
at the ZA was acutely perturbed by HGF.
Myosin VI is a processive actin-binding motor [15–17] that
controls the regional accumulation of dynamic actin filaments
during morphogenetic processes such as Drosophila sper-
matid differentiation [18, 19]. To pursue the notion that loss
of myosin VI from junctions might contribute to the acute
reduction in junctional F-actin in HGF-treated cells, we first
compared F-actin and myosin VI fluorescence intensity at
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Figure 1. HGF Acutely Perturbs the Zonula Adhe-
rens and Junctional Actin Cytoskeleton
(A–C) Confluent Caco-2 monolayers were treated
with HGF (5 ng/ml, 15min), stained for E-cadherin
(A), ZO-1 (B), and F-actin (C) and imaged at apical
junctions. (A) and (B) are double stained. Details
in boxed regions are on the right of each panel.
The scale bars represent 20 mm.
(D) Discontinuities in E-cadherin staining in
regions between the vertices of two contiguous
cells (contacts) (Means + standard error [SE];
n = 30, p < 0.005).
(E and F) Junctional F-actin measured by line
scan analysis of fluorescence (E) and peak inten-
sity from the line scan analysis (F). Means + SE;
n = 60; p < 0.0001.
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504junctions by cross-correlation analysis. F-actin and myosin VI
intensities were closely correlated in control cells (r = 0.7568,
p < 0.0001; n = 60) (Figure S1B), but both were reduced in
HGF-treated cells (r = 0.5279, p < 0.0001; Figure S1B). Further,
when we compared the time course of change in these two
proteins, we found that myosin VI and F-actin were both
reduced at the earliest time point analyzed (Figure S1C).
Together, these suggested that F-actin and myosin VI content
were coordinately reduced by HGF at the ZA.
If loss of junctional myosin VI was responsible for the acute
changes in junctional actin, we then predicted that restoring
myosin VI at junctions should block disruption of the junctional
cytoskeleton by HGF. Accordingly, we examined the impact of
HGF on junctions in cells that transiently overexpressed
porcine myosin VI (Figures 2G–2J). Exogenous myosin VI
accumulated at junctions even in HGF-treated cells (Figures
2G and 2H), suggesting that overexpression was able to coun-
teract the impact of HGF signaling on myosin VI localization.
Notably, apical actin rings were restored to junctions in cells
that displayed exogenous myosin VI at contacts (Figures 2G
and 2I), and apical ruffles reduced (not shown), despite HGF.
Overexpression of myosin VI also restored the integrity of
the ZA (Figures 2H and 2J). In contrast, neither the apical actin
rings nor ZA integrity were restored by a myosin VI mutant
lacking the motor head domain that binds F-actin (Figures 2I
and 2J). Although we do not exclude the possibility that other
actin regulators are also influenced by HGF, together these
findings indicate that disrupting the junctional localization of
myosin VI is a key step for HGF to acutely perturb ZA integrity
and the junctional actin cytoskeleton.
We then sought to better understand how HGF affects
F-actin content at the ZA. Even at steady state, the junctional
cytoskeleton is composed of dynamic actin filaments that
undergo assembly and disassembly [3, 20]. We assessed turn-
over dynamics by measuring fluorescence recovery after pho-
tobleaching of GFP-actin at the ZA (Figure 3A). GFP-actin
incorporated into junctional actin filaments and recovered
rapidly (T1/2 = 13.10 6 0.73 s) following photobleaching in
control cells. HGF treatment did not, however, affect the
kinetics of fluorescence recovery (T1/2 = 10.28 6 1.44 s; p =
not significant [NS], Student’s t test) or the degree of recovery(plateau in controls 0.89% + 0.03%
versus 0.91% + 0.003% in HGF-treated
cells, p = NS). Thus alterations in
filament assembly were unlikely to
account for the HGF-induced reduction
in junctional F-actin. Nor did we detectevidence for accelerated actin filament turnover by using
photoactivatable (PA)-GFP-tagged actin (Figure 3B).
PA-GFP-actin fluorescence at junctions in control cells de-
cayed progressively following photoactivation (T1/2 = 16.37 6
2.07 s), and this was unchanged in HGF-treated cells (T1/2 =
23.80 6 2.49 s; p = NS). These findings suggested that neither
decreased actin assembly nor accelerated filament turnover
could readily account for the impact of HGF on the junctional
cytoskeleton.
We then considered the possibility that HGF perturbed the
ability of cells to retain actin filaments at the junctions. To
investigate this, we examined the dynamic behavior of junc-
tional filaments by using either LifeAct [21] or the calponin
homology domain of utrophin (Utr-CHD) [22], which faithfully
bind actin filaments. We found that both reagents worked
equally well, identifying prominent apical rings of F-actin in
control monolayers that showed slight orthogonal movements
[3] but little change in fluorescence intensity (Figure S2A,
Movie S1). Kymographs confirmed that the apical actin rings
remained densely packed in controls (Figure 3C), whereas
this packing was lost after HGF (Figure S2A, Movie S2).
Instead, HGF appeared to cause F-actin to disperse outward
from the junctions (Figure 3C).
HGF-induced dispersal of junctional F-actin was quantified
by first converting data from the kymographs into surface
intensity plots (Figure S2B), which showed an obvious
widening of fluorescence in HGF-treated cells compared
with controls. We then applied a threshold at half of the peak
intensity at the time of treatment and determined the number
of pixels over threshold at each time point. The suprathresh-
hold pixel number remained relatively constant in control cells,
consistent with retention of filaments in tightly packed apical
rings. HGF-treated cells, however, showed a progressive
increase in the number of pixels above threshold, indicating
that the area of F-actin fluorescence was becoming broader
(Figure 3D).We conclude that HGFdisrupts the junctional actin
cytoskeleton by perturbing the ability of cells to retain actin
filaments at the ZA. Importantly, no dispersion of junctional
actin filaments occurred upon HGF treatment in cells that
also overexpressed GFP-myosin VI (Figures 3C and 3D,
Figures S2A and S2B, and Movie S3). This strongly implicates
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Figure 2. HGF Perturbs the Interaction between Myosin VI and the E-cadherin Molecular Complex
(A) Myosin VI can directly bind E-cadherin. Recombinant Myc-tagged myosin VI CBD was incubated with recombinant GST-E-cadherin cytoplasmic tail
(E-cad tail), with GST or with glutathione beads (Beads). Polypeptides were identified by Coomassie staining or immunoblotting for Myc.
(B) Loss of junctional myosin VI coincides with reduced junctional F-actin. Control and HGF-treatedmonolayers (5 ng/ml, 15min) immunostained for myosin
VI and phalloidin. Details in boxed regions are on the right of each panel. The scale bars represent 20 mm.
(C) Peak junctional myosin VI fluorescence (means 6 SE; n = 60; p < 0.0001).
(D) Junctional myosin VI fluorescence relative to E-cadherin (means + SE, n = 20, p < 0.0005).
(E and F) HGF perturbs themyosin VI-E-cadherin interaction. Confluent Caco-2 monolayers treated with HGF (5 ng/ml, 15min) with or without preincubation
with BAPTA-AM. Myosin VI immunocomplexes probed for myosin VI and E-cadherin. (F) Ratio of E-cadherin compared with Myosin VI (E-cad/MyoVI)
normalized to that of the untreated control immunoprecipitation (IP) (means + SE, ***p = 0.0004 compared with myosin VI IP; n = 3).
(G and H) Caco-2 cells transiently expressing GFP-tagged myosin VI or GFP alone were stimulated with HGF (5 ng/ml, 15 min) then immunostained for GFP
and either F-actin (G) or E-cadherin (H).
(I and J) Effect of expressing full-length myosin VI or a mutant lacking the motor head domain (GFP MyoVI-tail) in HGF-treated cells assessed by number of
cells with intact apical actin rings (I, n = 110-127) and E-cadherin ZA rings (J, n = 60) compared to GFP controls (data are means + SE).
See also Figure S1.
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505loss of myosin VI as key to the loss of filament anchorage in
HGF-treated cells.
Finally, we turned to investigate the signaling pathways that
mediated the impact of HGF on the junctional cytoskeleton.
Many intracellular signals are known to be activated when
HGF binds to its cellular receptor, Met [7]. So we first assessed
how drugs that inhibit specific major signaling pathways
affected the junctional cytoskeletal response to HGF(Figure 4A). The ability of HGF to reduce both junctional F-actin
and myosin VI was not affected by PD98059, which blocks the
ERK pathway, but it was effectively inhibited by both LY-
294002 and U-73122, which inhibit PI3-kinase and PLC,
respectively. Interestingly, both these signals have been linked
to pathways that ultimately regulate intracellular Ca2+ [23],
which can be stimulated by HGF [24–26]. To pursue the
possible role of Ca2+ signaling in acute junctional regulation
AControl HGF MyoVI + HGF
>
0 min
40 min
C
HGF
ControlControl
HGF
B
+ HGF/
D Figure 3. HGF Disrupts Retention of Actin Fila-
ments at Apical Junctions
(A) Junctional actin turnover measured by FRAP
of GFP-actin imaged at apical junctions. Data
are means 6 SE (n = 15).
(B) Junctional F-actin stability measured by fluo-
rescence decay after photoactivation of PA-GFP
actin imaged at apical junctions. Data are
means 6 SE (n = 18).
(C) Kymographs of LifeAct Ruby imaged at apical
junctions in controls, HGF-treated cells, and
myosin VI-expressing cells treated with HGF.
(Data from Movies S1–S3). Red lines marks
when buffer or HGF (5 ng/ml) was added.
(D) Lateral dispersion of junctional F-actin in
controls, cells treated with HGF and in myosin
VI-expressing cells treated with HGF (means +
SE, n = 6).
See also Figure S2 and Movies S1–S3.
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506by HGF, we first tested the effect of directly elevating intracel-
lular Ca2+. Acute treatment of cells with the calcium ionophore
ionomycin (10 mM, 30min) reduced both phalloidin andmyosin
VI staining at cell-cell junctions (Figure S3A). Thus, directly
increasing intracellular Ca2+ signaling induced changes similar
to those of HGF.
We then examined howHGFmight affect the junctional cyto-
skeleton when the cell-permeant Ca2+-chelator BAPTA-AM
was used to buffer intracellular Ca2+ against acute increases
(Figures 4B and 4D). Ca2+-buffering effectively prevented
HGF from disrupting junctional myosin VI or reducing F-actin
(Figures 4B–4D). Further, myosin VI and E-cadherin continued
to coimmunoprecipitate in cells treated with both BAPTA-AM
and HGF (Figures 2E and 2F). Together, these data suggest
that HGF acutely regulates the junctional cytoskeleton by acti-
vating intracellular Ca2+ signaling.
Conclusions
The junctional actin cytoskeleton contributes to cell-cell inter-
actions in many ways [3, 27, 28]. In turn, the junctional cyto-
skeleton is maintained by an ensemble of processes and theirControl HGF
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Cmolecular effectors, including regulators of actin filament
assembly [29–31] and mechanisms that potentially retain fila-
ments at the ZA [1, 2]. Our findings now demonstrate that dys-
regulation of the junctional cytoskeleton is a mechanism by
which junctional integrity can be perturbed. We propose that
HGF acutely uncouples myosin VI from E-cadherin, thereby
perturbing the ability of cells to retain actin filaments at the
ZA. This is consistent with the observed capacity of myosin
VI to promote the local accumulation of dynamic actin
networks [1, 19]. At the ZA, filament retention is likely funda-
mental for other actin-binding proteins to promote junctional
stability [3] and mechanotransduction [27], thereby preventing
the ZA fragmentation that we observed as an acute effect of
HGF. Of note, our findings further suggest that targeting cyto-
skeletal regulators, such as myosin VI, has the capacity to
induce very rapid changes in junctional integrity. Acute regula-
tion is likely to be important in physiological and pathological
processes that involve dynamic remodeling of cell-cell interac-
tions, such as cell-on-cell locomotion and EMT [32, 33]. It is
likely to complement other, slower, modes of cellular regula-
tion, such transcriptional modulation [8]. Although our current
findings focus on the role of myosin VI in retaining filaments atFigure 4. Calcium Signaling Is Implicated in
Acute Regulation of the Junctional Cytoskeleton
by HGF
(A) Junctional myosin VI and F-actin in control
and HGF-treated cells and in HGF-treated
cells preincubated with PD-98059, U-73122, or
LY-294002. Data are means 6 SE (n = 60, ***p <
0.0001 compared with controls, Student’s t test).
(B–D) Buffering intracellular calcium blocks the
impact of HGF on the junctional cytoskeleton.
Confluent Caco-2 cells incubated with BAPTA-
AM before HGF (5 ng/ml, 15 min) were immuno-
stained for myosin VI and F-actin. Peak fluores-
cence of junctional myosin VI (C) and F-actin
(D) (means + SE, ***p < 0.0001 compared with
control; n = 10–14).
See also Figure S3.
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507the ZA, the junctional cytoskeleton is also regulated by mole-
cules that determine actin filament dynamics, organization
and contractility. These provide additional potential targets
to perturb junctional integrity, that may also be influenced
by HGF. Dysregulation of the junctional actin cytoskeleton
may then be a general mechanism for junctions to be rapidly
remodeled in morphogenesis and disease.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, three figures, and three movies and can be found with this article
online at doi:10.1016/j.cub.2011.02.018.
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